We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-7.37%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$281M
AUM Growth
-$44.4M
(-14%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-5.8%
Top 10 Holdings %
Top 10 Hldgs %
48.11%
Holding
91
New
17
Increased
9
Reduced
22
Closed
24
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$18.9M |
| 2 |
AGN
Allergan plc
AGN
|
+$16.4M |
| 3 |
Pfizer
PFE
|
+$11M |
| 4 |
McKesson
MCK
|
+$8.96M |
| 5 |
Cencora
COR
|
+$8.86M |
Top Sells
| 1 |
GSK
GSK
|
+$15.2M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
+$12.1M |
| 3 |
Medpace
MEDP
|
+$10.2M |
| 4 |
Novartis
NVS
|
+$8.3M |
| 5 |
Humana
HUM
|
+$7.51M |
Sector Composition
| 1 | Healthcare | 90.79% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $20.7M | 7.35% |
179,714
+55,550
| +45% | +$8.43M |
|
|
2
Johnson & Johnson
JNJ
$611B
| $18.6M | 6.61% |
+143,707
| New | +$18.9M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $16.9M | 6.02% |
+100,629
| New | +$16.4M |
|
4
HCA Healthcare
HCA
$80.7B
| $16.2M | 5.76% |
134,599
-22,585
| -14% | -$2.92M |
|
|
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
| $13.1M | 4.65% |
50,435
-12,060
| -19% | -$3.33M |
|
6
Coherus Oncology
CHRS
$224M
| $12.3M | 4.36% |
604,785
+420,419
| +228% | +$8.4M |
|
|
7
Pfizer
PFE
$138B
| $10.3M | 3.66% |
+301,918
| New | +$11M |
|
8
Alnylam Pharmaceuticals
ALNY
$37.6B
| $9.86M | 3.51% |
122,653
-28,900
| -19% | -$2.29M |
|
9
Medtronic
MDT
$102B
| $8.77M | 3.12% |
80,702
-15,762
| -16% | -$1.64M |
|
|
10
McKesson
MCK
$94.1B
| $8.64M | 3.07% |
+63,190
| New | +$8.96M |
|
|
11
Cencora
COR
$58.8B
| $8.49M | 3.02% |
+103,103
| New | +$8.86M |
|
|
BEAT
12
DELISTED
BioTelemetry, Inc.
BEAT
| $7.78M | 2.77% |
191,040
+37,085
| +24% | +$1.6M |
|
|
MRTX
13
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.52M | 2.67% |
96,525
-38,775
| -29% | -$3.64M |
|
14
Avantor
AVTR
$7.71B
| $6.99M | 2.49% |
475,609
+254,022
| +115% | +$4.3M |
|
15
United Therapeutics
UTHR
$22.4B
| $6.99M | 2.49% |
87,664
+4,772
| +6% | +$384K |
|
16
Regeneron Pharmaceuticals
REGN
$68.8B
| $6.87M | 2.44% |
+24,776
| New | +$7.33M |
|
17
Elevance Health
ELV
$92.7B
| $6.55M | 2.33% |
27,285
-2,054
| -7% | -$563K |
|
18
InMode
INMD
$858M
| $5.79M | 2.06% |
+538,766
| New | +$6.14M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.31M | 1.89% |
369,494
-156,565
| -30% | -$2.24M |
|
20
Viking Therapeutics
VKTX
$4.41B
| $5.19M | 1.85% |
754,759
| – | – |
|
|
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.13M | 1.83% |
619,019
+15,000
| +2% | +$121K |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.02M | 1.79% |
51,281
-20,240
| -28% | -$2.28M |
|
23
Halozyme
HALO
$8.9B
| $4.97M | 1.77% |
+320,373
| New | +$5.28M |
|
|
24
Medpace
MEDP
$15.3B
| $4.32M | 1.54% |
51,401
-134,414
| -72% | -$10.2M |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.23M | 1.5% |
40,182
-2,000
| -5% | -$211K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA